I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| pericyte | 19 studies | 25% ± 8% | |
| smooth muscle cell | 11 studies | 27% ± 9% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| pericyte | 19 studies | 25% ± 8% | |
| smooth muscle cell | 11 studies | 27% ± 9% |
Insufficient scRNA-seq data for expression of FHL5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| breast | 95% | 1557.80 | 437 / 459 | 73% | 2.84 | 814 / 1118 |
| lung | 96% | 1172.40 | 553 / 578 | 68% | 2.62 | 787 / 1155 |
| thymus | 90% | 921.19 | 586 / 653 | 74% | 3.63 | 448 / 605 |
| esophagus | 55% | 482.36 | 791 / 1445 | 66% | 2.51 | 121 / 183 |
| brain | 12% | 74.88 | 324 / 2642 | 99% | 5.65 | 695 / 705 |
| bladder | 71% | 558.33 | 15 / 21 | 39% | 1.09 | 198 / 504 |
| prostate | 42% | 408.85 | 102 / 245 | 69% | 2.29 | 344 / 502 |
| adrenal gland | 40% | 225.93 | 104 / 258 | 66% | 3.74 | 152 / 230 |
| kidney | 36% | 238.92 | 32 / 89 | 70% | 14.90 | 634 / 901 |
| uterus | 84% | 1454.39 | 143 / 170 | 20% | 0.57 | 90 / 459 |
| intestine | 48% | 457.45 | 464 / 966 | 53% | 1.62 | 280 / 527 |
| blood vessel | 100% | 12826.12 | 1329 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 2724.17 | 1193 / 1204 | 0% | 0 | 0 / 0 |
| pancreas | 5% | 24.19 | 16 / 328 | 90% | 6.14 | 161 / 178 |
| stomach | 25% | 213.52 | 89 / 359 | 70% | 2.38 | 199 / 286 |
| muscle | 59% | 406.81 | 474 / 803 | 0% | 0 | 0 / 0 |
| ovary | 44% | 810.51 | 80 / 180 | 7% | 0.24 | 32 / 430 |
| skin | 26% | 208.19 | 474 / 1809 | 25% | 0.62 | 120 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 29% | 0.60 | 13 / 45 |
| liver | 0% | 3.63 | 1 / 226 | 16% | 0.44 | 64 / 406 |
| heart | 14% | 86.81 | 118 / 861 | 0% | 0 | 0 / 0 |
| spleen | 7% | 46.37 | 18 / 241 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 6% | 0.16 | 5 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0030018 | Cellular component | Z disc |
| GO_0005634 | Cellular component | nucleus |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | FHL5 |
| Protein name | Four and a half LIM domains protein 5 (FHL-5) (Activator of cAMP-responsive element modulator in testis) (Activator of CREM in testis) Four and a half LIM domains protein 5 |
| Synonyms | ACT |
| Description | FUNCTION: May be involved in the regulation of spermatogenesis. Stimulates CREM transcriptional activity in a phosphorylation-independent manner. . FUNCTION: May be involved in the regulation of spermatogenesis. Stimulates CREM transcriptional activity in a phosphorylation-independent manner. . |
| Accessions | ENST00000326771.2 ENST00000450218.6 ENST00000541107.5 ENST00000450218 Q5TD97 X6RED3 |
